The sense that the UK Medicines and Healthcare products Regulatory Agency (MHRA) may have a contingency plan to ensure device manufacturers have enough time to comply with the new UKCA marking regulation grows with every week that the MHRA/government response to the UKCA marking consultation is delayed.
This promised document ̶ the next stage in the process to establish UK-specific device regulation ̶ is already many weeks behind schedule. This suggests that compliance with the 1 July...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?